![](/img/cover-not-exists.png)
Biomarker Signatures Correlate with Clinical Outcome in Refractory Metastatic Colorectal Cancer Patients Receiving Bevacizumab and Everolimus
Liu, Y., Starr, M. D., Brady, J. C., Rushing, C., Bulusu, A., Pang, H., Honeycutt, W., Amara, A., Altomare, I., Uronis, H. E., Hurwitz, H. I., Nixon, A. B.Volume:
14
Language:
english
Journal:
Molecular Cancer Therapeutics
DOI:
10.1158/1535-7163.MCT-14-0923-T
Date:
April, 2015
File:
PDF, 1.23 MB
english, 2015